Stivarga 40 MG tablet 21S
Ended Awarded Last action
- Contract number
- SPE2DR26FCYY1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,429
Award facts
- Contract value 100% obligated
- $31,429.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,429.26 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of STIVARGA 40 mg tablets (21-count units). This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was funded by the Defense Logistics Agency and executed under the company's recently established Indefinite Delivery Contract with the agency.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $499.9 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrates its capability to fulfill the diverse pharmaceutical requirements of the federal military medical system, with no subcontractors identified in the award documentation.
Quick answers
Who was awarded contract SPE2DR26FCYY1?
SPE2DR26FCYY1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FCYY1 worth?
The government has obligated $31,429 on SPE2DR26FCYY1.
Is contract SPE2DR26FCYY1 an order under another contract?
Yes. SPE2DR26FCYY1 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYY1 competed?
The extent of competition for SPE2DR26FCYY1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award